Lise Lavoie

Title: Lise Lavoie: Innovator in Biological Adhesives

Introduction

Lise Lavoie is a notable inventor based in St-Eustache, Canada. She has made significant contributions to the field of biomedical engineering, particularly in the development of biological adhesives. Her innovative work has led to the creation of a patented process that enhances the efficacy of surgical procedures.

Latest Patents

Lavoie holds a patent for a process for the obtention of a biological adhesive made of concentrated coagulation proteins. This invention relates to a method of producing a concentrate of coagulation proteins from whole human or animal plasma. The resulting concentrate is utilized as a biological adhesive when mixed with thrombin. The concentrated proteins primarily consist of fibrinogen, fibrin stabilizing factor (factor XIII), and fibronectin. The process is advantageous due to its efficiency and high yield of coagulable proteins, without the need for protease inhibitors. The proteins obtained are stable for at least 24 hours when reconstituted in water, demonstrating excellent strength and biocompatibility when mixed with thrombin and calcium.

Career Highlights

Lise Lavoie has been instrumental in advancing the field of biological adhesives through her innovative research and development. Her work at Haemacure Biotech Inc. has positioned her as a leader in the industry. She has successfully translated her research into practical applications that benefit surgical practices.

Collaborations

Lavoie has collaborated with notable colleagues, including Trung Bui-Khac and Dominique Michel St Picq. These partnerships have further enhanced her research and contributed to the success of her inventions.

Conclusion

Lise Lavoie is a pioneering inventor whose work in biological adhesives has the potential to transform surgical procedures. Her patented process exemplifies innovation in the biomedical field, showcasing her commitment to improving patient outcomes.